Nath Bio-Genes Share Price Today | Stock Price & Nath Bio-Genes Share Screener
As of October 5, 2026, the live Nath Bio-Genes share price (NSE: NATHBIOGEN) is ₹134.29 on NSE and ₹134.20 on BSE, down 2.50% from the previous close, with shares trading between ₹133.00 and ₹142.44 in today's trading session, and a 52-week range of ₹129.02–₹196.01. Check NATHBIOGEN annual price range for the annual price range and momentum. Use the Nath Bio-Genes stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Nath Bio-Genes opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹332 and net income of ₹32, with EBITDA of ₹38, an operating margin of 11.0% and a profit margin of 9.6%.
Nath Bio-Genes Share Price Chart
Track the current stock price of Nath Bio-Genes with an interactive chart. Analyse NATHBIOGEN share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Nath Bio-Genes stock quote in one place.
The quote of ₹134.29 sits between the 52-week low of ₹129.02 and the 52-week high of ₹196.01, and the latest session moved -2.50% from the previous close.
Nath Bio-Genes Company Profile - Fundamental Screener
Screen Nath Bio-Genes company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for NATHBIOGEN shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the FMCG sector and the Agricultural Products industry, and it trades under ISIN INE448G01010.
Company Details
Classification
Identifiers and Leadership
Nath Bio-Genes Balance Sheet Screener
Screen NATHBIOGEN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2025, total assets were ₹1,026, up from ₹880 in 2024.
Latest statistics put total assets at ₹1,026 and shareholder funds at ₹644, with a leverage ratio of 0.19.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Assets |
||||
| Total Assets | 1,026 | 880 | 793 | 740 |
| Current Assets | 690 | 572 | 521 | 468 |
| Fixed Assets | 250 | 250 | 244 | 245 |
Liabilities |
||||
| Total Liabilities | 0 | 0 | 0 | 0 |
| Current Liabilities | 17 | 8 | 3 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||
| Total Equity | 644 | 610 | 573 | 542 |
| Share Capital | 19 | 19 | 19 | 19 |
| Reserves & Surplus | 625 | 591 | 554 | 523 |
Nath Bio-Genes Income Statement Screener - Profit & Revenue Analysis
Screen Nath Bio-Genes income statement and profit fundamentals. Analyze NATHBIOGEN quarterly results. Nath Bio-Genes reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Jun, revenue was ₹332 and net profit was ₹32, equal to earnings per unit of ₹16.98, at an operating margin of 11%.
In that period expenses were ₹293, interest cost ₹4 and tax ₹1. The next period listed, 2026-Mar, shows revenue of ₹55 and net profit of ₹0.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 332 | 55 | 70 | 48 | 288 | 56 | 37 | 32 | 244 | 44 | 34 | 23 | 235 | 45 | 25 |
| Expenses | 293 | 47 | 62 | 38 | 254 | 52 | 29 | 27 | 207 | 39 | 26 | 18 | 198 | 41 | 20 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 38 | 8 | 8 | 10 | 33 | 5 | 9 | 5 | 37 | 5 | 8 | 5 | 37 | 4 | 6 |
| Operating Profit % | 11.00% | 9.00% | 5.00% | 14.00% | 10.00% | 1.00% | 22.00% | 15.00% | 15.00% | 9.00% | 18.00% | 22.00% | 16.00% | 9.00% | 22.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 4 | 5 | 5 | 4 | 3 | 1 | 4 | 3 | 2 | 1 | 3 | 2 | 3 | 2 | 3 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 33 | 3 | 3 | 6 | 29 | 2 | 4 | 1 | 34 | 3 | 5 | 2 | 34 | 2 | 2 |
| Tax | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| Net Profit | 32 | 0 | 2 | 5 | 28 | 2 | 3 | 1 | 33 | 3 | 4 | 2 | 33 | 1 | 1 |
| EPS | 16.98 | -0.79 | 0.89 | 2.53 | 14.88 | 0.42 | 1.33 | 0.53 | 17.49 | 1.87 | 2.02 | 0.86 | 17.59 | 0.77 | 0.71 |
Nath Bio-Genes Cash Flow Screener - Liquidity Fundamentals
Screen NATHBIOGEN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities generated ₹18, and net cash flow was an inflow of ₹12.
Over the same period, investing activities used ₹4 and financing activities used ₹2.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
Cash from Operations and Investing | ||||
| Operating Activities | 18 | 75 | 38 | 17 |
| Investing Activities | -4 | -27 | -3 | -20 |
Financing and Net Cash | ||||
| Financing Activities | -2 | -8 | -2 | -22 |
| Net Cash Flow | 12 | 39 | 34 | -25 |
Nath Bio-Genes Shareholding Pattern Screener
See Nath Bio-Genes shareholding pattern with promoter, FII, and DII holdings. Check Nath Bio-Genes promoter holding and ownership changes for NATHBIOGEN on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 45.60%, foreign institutions 0.23%, domestic institutions 0.01% and the public 34.39%, spread across 33,031 shareholders.
The shareholder count was 33,031 in 2026-Mar, compared with 32,564 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% |
Institutional Investors | ||||||||
| FII Holding | 0.23% | 0.27% | 0.21% | 0.42% | 0.32% | 0.31% | 0.27% | 0.22% |
| DII Holding | 0.01% | 0.01% | 3.94% | 2.25% | 0.76% | 0.01% | 4.37% | 4.38% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 34.39% | 34.37% | 31.94% | 32.98% | 33.78% | 34.22% | 32.25% | 32.43% |
| Other Holding | 19.77% | 19.76% | 18.31% | 18.76% | 19.54% | 19.87% | 17.51% | 17.39% |
| Shareholder Count | 33,031 | 32,564 | 34,911 | 34,207 | 34,122 | 33,550 | 35,132 | 35,834 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Nath Bio-Genes. Nath Bio-Genes dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹2.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹2.00 and ₹2.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹2.00 | 1.55% |
| 2024-March | ₹2.00 | 1.37% |
| 2023-March | ₹2.00 | 1.15% |
| 2022-March | ₹2.00 | 1.43% |
| 2021-March | ₹2.00 | 0.94% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Nath Bio-Genes Stock Index Membership - Nifty & Sensex
See which indices include Nath Bio-Genes stock. Check NATHBIOGEN index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Nath Bio-Genes Market Events Screener - Corporate Actions
Get Nath Bio-Genes corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Nath Bio-Genes stock events that may affect NATHBIOGEN share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 24, 2026, with a record date of September 24, 2026.
It is followed by Dividend dated September 11, 2026 and Quarterly Result Announcement dated July 29, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-24 | 2026-09-24 | Annual General Meeting | NA | -9.91% |
| 2026-09-11 | 2026-09-11 | Dividend | ₹ 2.00 /share | -23.65% |
| 2026-07-29 | 2026-07-29 | Quarterly Result Announcement | NA | 2.41% |
| 2026-05-04 | 2026-05-04 | Quarterly Result Announcement | NA | 15.33% |
| 2026-01-31 | 2026-01-31 | Quarterly Result Announcement | NA | 2.36% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -3.99% |
| 2025-08-22 | 2025-08-22 | Annual General Meeting | NA | 12.38% |
| 2025-08-14 | 2025-08-14 | Dividend | ₹ 2.00 /share | 11.66% |
| 2025-07-11 | 2025-07-11 | Quarterly Result Announcement | NA | 8.01% |
| 2025-04-29 | 2025-04-29 | Quarterly Result Announcement | NA | -6.81% |
| 2025-01-23 | 2025-01-23 | Quarterly Result Announcement | NA | 0.03% |
| 2024-10-23 | 2024-10-23 | Quarterly Result Announcement | NA | -3.86% |
| 2024-08-17 | 2024-08-17 | Annual General Meeting | NA | 8.77% |
| 2024-08-09 | 2024-08-09 | Dividend | ₹ 2.00 /share | 12.01% |
| 2024-03-12 | 2024-03-12 | Extraordinary General Meeting | NA | -11.30% |
Nath Bio-Genes Competitors Screener - Peer Stocks Comparison
Screen NATHBIOGEN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the FMCG sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| LT Foods | 14,185 | 22.90 | 11,023 | 25.69% | 625 | 39.07 |
| KRBL | 8,765 | 12.06 | 6,168 | 9.07% | 648 | 39.21 |
| Gujarat Ambuja Exports | 7,360 | 18.05 | 5,836 | 24.30% | 304 | 45.10 |
| Kaveri Seed Company | 3,958 | 16.68 | 1,424 | 13.81% | 296 | 55.34 |
| Trualt Bioenergy | 3,929 | 23.79 | 1,814 | -7.85% | 97 | 62.61 |
| Sanstar | 2,141 | 63.11 | 785 | -27.46% | 35 | 41.35 |
| Amir Chand Jagdish Kumar (Exports) | 2,082 | 17.48 | 2,287 | 14.13% | 103 | 55.42 |
| GRM Overseas | 1,658 | 21.84 | 1,806 | 31.41% | 76 | 36.26 |
| Chaman Lal Setia Exports | 1,421 | 11.68 | 1,450 | -3.56% | 115 | 43.24 |
| Avt Natural Products | 1,319 | 16.84 | 727 | 27.04% | 65 | 47.78 |
Nath Bio-Genes Company Announcements - News & Reports Screener
Screen NATHBIOGEN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated October 2, 2026 and September 5, 2026.
| Date | Update | Actions |
|---|---|---|
| Closure of Trading Window | - | |
| 2026-10-02 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-05 | Corporate Action-Board to consider Dividend | - |
| 2026-09-04 | Corporate Action-Board to consider Dividend | - |
| 2026-09-01 | Record Date | - |
| 2026-09-01 | Reg. 34 (1) Annual Report. | - |
| 2026-09-01 | Intimation Of Annual General Meeting | - |
| 2026-08-06 | Announcement Under Reg 30 Of SEBI (LODR) | - |
| 2026-07-30 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-07-29 | Financial Results As Of 30Th June 2026. | - |
| 2026-07-23 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-18 | Board Meeting Intimation for Approval Of Financial Results | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-05-28 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-11 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-11 | NBIL Concall | - |
| 2026-05-11 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-05-04 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-04 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-05-04 | Outcome Of Board Meeting | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹134.29, within a 52-week range of ₹129.02 to ₹196.01. The P/E ratio is 7.36 and the P/B ratio is 0.42, with earnings per unit of ₹20.98. Market capitalisation stands at ₹273.89 Cr and the dividend yield is 1.33%. The company operates in the FMCG sector, in the Agricultural Products industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 4 balance sheet periods, 15 income statement periods, 4 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.